Evidence map›Paper›PMID 23267103›Full record

SynthesisProceedings of the National Academy of Sciences of the United States of America2013

Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association.

Karl C Desch, Ayse B Ozel, David Siemieniak, Yossi Kalish, Jordan A Shavit, Courtney D Thornburg, Anjali A Sharathkumar, Caitlin P McHugh, Cathy C Laurie, Andrew Crenshaw and 12 more

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 7 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 7 syntheses or guidelines pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Genetic Variants Associated with Circulating Fibroblast Growth Factor 23.Journal of the American Society of Nephrology : JASN · 2018
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Fine-scale regional frequency of theERJ open research · 2025
    Article
  16. Article
  17. Thrombotic risk determined byResearch and practice in thrombosis and haemostasis · 2025
    Article
  18. Article
  19. Genome-Wide Scan of Fifth Finger Clinodactyly.Molecular genetics & genomic medicine · 2025
    Article
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 13 institutions in 5 countries.

Karl C DeschDepartment of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI 48109, USA.
Ayse B Ozel
David Siemieniak
Yossi Kalish
Jordan A Shavit
Courtney D Thornburg
Anjali A Sharathkumar
Caitlin P McHugh
Cathy C Laurie
Andrew Crenshaw
Daniel B Mirel
Yoonhee Kim
Cheryl D Cropp
Anne M Molloy
Peadar N Kirke
Joan E Bailey-Wilson
Alexander F Wilson
James L Mills
John M Scott
Lawrence C Brody
Jun Z Li
David Ginsburg
National Human Genome Research Institute · USCenter for Non-Communicable Diseases · PKBroad Institute · USInstitute of Human Genetics · PLUniversity of Washington · USDuke University · USEunice Kennedy Shriver National Institute of Child Health and Human Development · USHadassah Medical Center · ILHealth Research Board · IEHoward Hughes Medical Institute · USNational Institutes of Health · USNorthwestern University · USTrinity College Dublin · IE

Funding

Genometric analysis of quantitative traitsZIAHG000200 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI WILSON, ALEXANDER F · 2009 to 2020
$19.8M
The contribution folate and vitamin B12 genes to disease.ZIAHG000167 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BRODY, LAWRENCE C · 2009 to 2025
$17.6M
Genetic Epidemiology of Complex TraitsZIAHG200327 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BAILEY-WILSON, JOAN ELLEN · 2009 to 2022
$10.5M
Advancing Child Health Through Cellular and Molecular BiologyK12HD028820 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Donna M. Martin · 2002 to 2026
$9.2M
NICHD Health Research Board Of Ireland Neural Tube Defects StudyZIAHD002502 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI MILLS, JAMES · 2009 to 2022
$2.9M
Molecular Genetic Study of von Willebrand FactorR01HL039693 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GINSBURG, DAVID · 1989 to 2016
$2.4M
Identifying novel genetic risk factors for venous thromboembolism (VTE)R01HL112642 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GINSBURG, DAVID, LI, JUN · 2012 to 2015
$1.5M
Howard Hughes Medical InstituteIntramural NIH HHSNHLBI NIH HHS 2R01HL039693NHLBI NIH HHS R01 HL039693NHLBI NIH HHS R01 HL112642NICHD NIH HHS 5K12HD028820-15NICHD NIH HHS K12 HD028820
6 · The paper itself

Abstract

The plasma glycoprotein von Willebrand factor (VWF) exhibits fivefold antigen level variation across the normal human population determined by both genetic and environmental factors. Low levels of VWF are associated with bleeding and elevated levels with increased risk for thrombosis, myocardial infarction, and stroke. To identify additional genetic determinants of VWF antigen levels and to minimize the impact of age and illness-related environmental factors, we performed genome-wide association analysis in two young and healthy cohorts (n = 1,152 and n = 2,310) and identified signals at ABO (P < 7.9E-139) and VWF (P < 5.5E-16), consistent with previous reports. Additionally, linkage analysis based on sibling structure within the cohorts, identified significant signals at chromosome 2q12-2p13 (LOD score 5.3) and at the ABO locus on chromosome 9q34 (LOD score 2.9) that explained 19.2% and 24.5% of the variance in VWF levels, respectively. Given its strong effect, the linkage region on chromosome 2 could harbor a potentially important determinant of bleeding and thrombosis risk. The absence of a chromosome 2 association signal in this or previous association studies suggests a causative gene harboring many genetic variants that are individually rare, but in aggregate common. These results raise the possibility that similar loci could explain a significant portion of the "missing heritability" for other complex genetic traits.

Indexed as

ABO Blood-Group SystemAdolescentAdultAge FactorsChromosomes, Human, Pair 2Chromosomes, Human, Pair 9Computational BiologyGene FrequencyGenetic LinkageGenome-Wide Association StudyGenotypeHaplotypesHumansLod ScorePolymorphism, Single NucleotidePrincipal Component AnalysisABO Blood-Group Systemvon Willebrand Factor

Identifiers

PMID23267103
PMCPMC3545809
OpenAlexW2008379906

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.